HFA Premium Access

Can we start quadruple therapy in new-diagnosed heart failure patients in real life? Insights into the basal characteristics of TIDY-HF register

Congress Session

About the speaker

Doctor Alberto Esteban Fernandez

Hospital Severo Ochoa, Madrid (Spain)
0 follower

37 more presentations in this session

Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis

Speaker: Doctor J. Diaz Acevedo (Bogota, CO)

Thumbnail

Position and cardiorenal mechanisms of uromodulin in heart failure

Speaker: Doctor L. Emmens (Groningen, NL)

Thumbnail

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Speaker: Doctor E. Barge Caballero (A Coruna, ES)

Thumbnail

Hepatic T1-time is a strong and independent predictor of cardiovascular outcome in all-comers referred for cardiac magnetic resonance imaging

Speaker: Doctor K. Mascherbauer (Vienna, AT)

Thumbnail

Virtual management of HF outpatient during COVID-19 pandemic period: a comparison with traditional follow up

Speaker: Doctor S. Prosperi (Rome, IT)

Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 4

Speakers: Doctor A. Esteban Fernandez, Doctor J. Diaz Acevedo, Doctor L. Emmens, Doctor E. Barge Caballero, Doctor K. Mascherbauer...
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Related content

Open Access

SGLT-2 Inhibitors in Heart Failure: Where are we now and where are we heading?

27 August 2021

ESC Premium Access

Efficacy of ARNI in real-world

27 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

This platform is supported by

logo Novo Nordisk